These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6715081)

  • 1. A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen.
    Houghton GW; Dennis MJ; Templeton R; Calvert RM; Cresswell DG
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):131-3. PubMed ID: 6715081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic profile of a slow-release ketoprofen preparation].
    Flouvat B; Stheneur A; Massias P
    Sem Hop; 1983 Dec; 59(46):3187-90. PubMed ID: 6318337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of controlled release ketoprofen in elderly patients.
    Dennis MJ; French PC; Crome P; Babiker M; Shillingford J; Hopkins R
    Br J Clin Pharmacol; 1985 Dec; 20(6):567-73. PubMed ID: 4091989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of ketoprofen derived from single oral doses of ketoprofen capsules or a novel sustained-release pellet formulation.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Biopharm Drug Dispos; 1984; 5(3):203-9. PubMed ID: 6487749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a slow-release preparation of ketoprofen lysine in man.
    Borsa M; Tonon GC; Ronchi C; Zanolo G; Canali S
    Arzneimittelforschung; 1983; 33(10):1497-500. PubMed ID: 6418181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of meal size and composition on the bioavailability of ketoprofen (Oruvail).
    Nievel JG; Havard CW; Mitchell P; Gudgeon A; Kaye CM
    Xenobiotica; 1987 Apr; 17(4):487-92. PubMed ID: 3604255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of ketoprofen in the synovial fluid].
    Kennedy AC
    Sem Hop; 1983 Dec; 59(46):3208-9. PubMed ID: 6318342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The bioavailability of ketoprofen (Profenid) administered orally in combination with a gastric protector (aluminum phosphate, Phosphalugel)].
    Tamisier JN; Brazier JL; Ambert D; Bannier A
    Sem Hop; 1983 Dec; 59(46):3214-7. PubMed ID: 6318344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability study on a new slow-release formulation of ketoprofen.
    Caruso I; Frigerio E; Fumagalli M; Liverta C; Moro L; Tamassia V
    J Int Med Res; 1982; 10(4):229-33. PubMed ID: 7117681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ketoprofen in man after repeated percutaneous administration.
    Flouvat B; Roux A; Delhotal-Landes B
    Arzneimittelforschung; 1989 Jul; 39(7):812-5. PubMed ID: 2783185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of ketoprofen in man during and after repeated oral dosing (50 mg q.i.d.) with Orudis.
    Lewellen OR; Templeton R
    Scand J Rheumatol Suppl; 1976; 1976(0):53-62. PubMed ID: 1068516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary pharmacokinetics of orally administered ketoprofen in man.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):201-4. PubMed ID: 6519121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen in patients with rheumatoid arthritis.
    McCrea JD; Telford AM; Kaye CM; Boyd MW
    Curr Med Res Opin; 1986; 10(2):73-81. PubMed ID: 3519094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the absorption of ketoprofen topically administered in man: comparison between tissue and plasma levels.
    Ballerini R; Casini A; Chinol M; Mannucci C; Giaccai L; Salvi M
    Int J Clin Pharmacol Res; 1986; 6(1):69-72. PubMed ID: 3957503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone (Imovane).
    Houghton GW; Dennis MJ; Templeton R; Martin BK
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):97-100. PubMed ID: 3988401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, interpatient comparison of plain and slow-release ketoprofen in osteoarthritis.
    Marcolongo R; Rubegni M; Provvedi D; Giordano N; Frati E; Bruni G
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):377-81. PubMed ID: 6381334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoprofen extended-release capsules: a new formulation for the treatment of osteoarthritis and rheumatoid arthritis.
    Schumacher HR
    Clin Ther; 1994; 16(2):145-59. PubMed ID: 8062310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic profil of ketoprofen (author's transl)].
    Caillé G; Besner JG; Brodeur J; Vezina M
    Ann Pharm Fr; 1978; 36(5-6):243-52. PubMed ID: 707953
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetics of ketoprofen in patients with renal failure].
    Stafanger G; Larsen HW; Hansen H; Serensen K
    Sem Hop; 1983 Dec; 59(46):3191-3. PubMed ID: 6318338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic pharmacokinetic studies of slow release ketoprofen (Oruvail) in rheumatoid arthritis.
    Christophidis N; Rotstein A; Louis WJ
    Clin Exp Pharmacol Physiol; 1986 Jul; 13(7):555-61. PubMed ID: 3791708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.